Published: 9 March 2020

Committees

Summary of Recommendations from the 108th meeting of the Medicines Assessment Advisory Committee held on 13 NOVEMBER 2019 at 9:30 am

5.

Applications for consent to distribute a new medicine under section 20 / 23 / 24 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2))

5.1

Clonazepam tablets, 0.5 mg (TT50-9877)
Boucher & Muir Pty Ltd


Recommendation

Secretary’s note – the recommendation has not been published because Boucher & Muir Pty Ltd withdrew this application on 5 March 2020, following notification of the recommendation.

Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /